Sort
78,016 grants matching “breast cancer”
Molecular breast imaging to guide early-stage patient care
$1,000,000Douglas J. Wagenaar · Gamma Medica-Ideas, Inc. · R44 · FY2009 · CA
Establishment of Molecular Biomedical Imaging Laboratory
$1,000,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2009 · EB
Exosomal Drug Delivery
$1,000,000Wendy A Spencer · 3p Biotechnologies, Inc. · R44 · FY2018 · CA
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America
$1,000,000Rafael Guerrero-Preston · Lifegene-Biomarks, Inc. · R44 · FY2023 · CA
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
SBIR Phase II: Non-planar Spectral Breast Computed Tomography (CT)
$1,000,000Peymon Ghazi · Malcova Inc · · FY2023 · TIP
DCTD Cancer Diagnosis
$1,000,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Image-Guided Stereotactic Radiosurgery of Breast Cancer
$1,000,000Christopher Jude Amies · Xcision Medical Systems, Llc · R44 · FY2010 · CA
OTHER FUNCTIONS: TOPIC 287, PHASE II "NANOTECHNOLOGY SENSING PLATFORMS"
$1,000,000Swapnajit Chakravarty · Omega Optics, Inc. · N44 · FY2012 · CA
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$1,000,000Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2019 · CA
Novel siRNA-nanoparticle Platform for Treating Drug-Resistant HER2 Positive Breas
$1,000,000David Castro · Pdx Pharmaceuticals, Inc. · N43 · FY2014 · CA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2018 · CA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2019 · CA
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2020 · TS
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2019 · TS
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
$1,000,000David S. Silberstein · Biomimetix Jv, Llc · R44 · FY2020 · CA
University of Michigan Comprehensive Cancer Center Support Grant
$1,000,000Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2006 · CA
Low Cost Automated Ultrasound for Breast Cancer Detection and Diagnosis
$1,000,000Susan M Love · Dr. Susan Love Research Foundation · UH3 · FY2016 · CA
Program 1: Therapeutic Development Program (TDP)
$1,000,000William R. Montfort · University Of Arizona · P30 · FY2020 · CA
Scaling Social Determinants of Health Screening, Social Support and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Wellbeing in Washington, DC
$1,000,000Hannah Arem · Medstar Health Research Institute · U01 · FY2022 · DP
SPORE IN BREAST CANCER
$1,000,000Duke University · P50 · FY2000 · CA
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2023 · CA
SCH: A Multi-Modal Transfer Learning Framework to Maximize Health Outcomes for Breast Cancer
$1,000,000Shibiao Wan · University Of Nebraska Medical Center · · FY2025 · CSE
SBIR Phase II: Antibody-Drug Conjugates (ADCs) with High Drug-Antibody Ratios (DAR) and Molecularly Targeted Payloads
$1,000,000Yivan Jiang · Window Therapeutics, Inc. · · FY2025 · TIP
Low Cost Automated Ultrasound for Breast Cancer Detection and Diagnosis
$1,000,000Susan M Love · Dr. Susan Love Research Foundation · UH3 · FY2017 · CA